Neurological cancer and other neurodegenerative diseases are amongst the most crippling illnesses with the greater portion of infected individuals not projected to survive past five years of initial diagnosis depending on the severity, stage, and form of the disease; the research in this project will identify the neurological molecular mechanisms of specific biological markers increasingly found to be identified in instances of these diseases, specifically c Jun kinase, which upon identification will be inhibited by utilizing SAB antibodies. Consequently, further damage such as mutation in the mitochondrial DNA and stress including cascades of apoptotic signaling pathways will be entirely halted, providing a highly effective treatment to the aforementioned neurodegenerative diseases.
